A 90-kDa Protein Serum Marker for the Prediction of Progression to AIDS in a Cohort of HIV-1+Homosexual Men
- 1 September 1993
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 9 (9) , 811-816
- https://doi.org/10.1089/aid.1993.9.811
Abstract
Levels of a 90-kDa protein (90K), recently reported as a possible marker of HIV-1 infection, were serially examined in a group of HIV-1-infected (HIV-1+) and uninfected (HIV-1-) subjects drawn from the same cohort of homosexual men. The first phase of the study included 61 HIV-1+ AIDS-free subjects 4 years (± 6 months) postseroconversion and 75 contemporaneous uninfected subjects. Two years later, a subset of 35 HIV-1+ AIDS-free subjects and 72 HIV-1- controls was examined. Mean 90K levels for HIV-1+ subjects were significantly higher than for contemporaneous HIV-1- subjects both 4 and 6 years postseroconversion (p < 0.0001). A significantly more rapid progression to AIDS was seen in HIV-1+ subjects with high 90K levels both 4 years (p = 0.01) and 6 years (p = 0.003) postseroconversion. Four years postseroconversion, 90K was significantly correlated with CD8 cell percent, interferon, neopterin, and β2-microglobulin (p < 0.05). Two years later, significant correlations were seen between 90K levels and CD4 cell percent, CD4 cell number, and β2-microglobu!in (p < 0.05). Stepwise-stepdown regression modeling using 90K, CD4 cell percent, interferon, and β2-microglobulin levels 4 years postseroconversion showed that the predictive value of a trivariate model of 90K-interferon-CD4 percent was better than any univariate or bivariate model. We conclude that the 90K protein may be a useful predictor of progression to AIDS in HIV-1+ patients, particularly in combination with the established markers of CD4 cell percent and interferon.Keywords
This publication has 18 references indexed in Scilit:
- Purification and characterization of a 90 kDa protein released from human tumors and tumor cell linesFEBS Letters, 1993
- Lipoprotein 90K in Human Immunodeficiency Virus-Infected Patients: A Further Serologic Marker of ProgressionThe Journal of Infectious Diseases, 1991
- Unusually High Level of a Tumor-Associated Antigen in the Serum of Human Immunodeficiency Virus-Seropositive IndividualsThe Journal of Infectious Diseases, 1991
- Book ReviewSexual Exploitation in Professional RelationshipsNew England Journal of Medicine, 1990
- Serum beta2-microglobulin level increases in HIV infectionAIDS, 1990
- The Prognostic Value of Cellular and Serologic Markers in Infection with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1990
- Recombinant human leukocyte interferon‐α 2b stimulates the synthesis and release of a 90k tumor‐associated antigen in human breast cancer cellsInternational Journal of Cancer, 1988
- Three-Year Incidence of AIDS in Five Cohorts of HTLV-III-Infected Risk Group MembersScience, 1986
- DETERMINANTS OF RETROVIRUS (HTLV-III) ANTIBODY AND IMMUNODEFICIENCY CONDITIONS IN HOMOSEXUAL MENThe Lancet, 1984
- Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas findings in a multicenter study and experience in selected patientsCancer, 1980